Condition
Melanoma Stage IIIB-IV clinical trials and research
Research outlook What's coming for Melanoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Melanoma Stage IIIB-IV clinical trials that are recruiting, at sites in 2 countries (most in Norway (1), United States (1)). By phase: Phase 2 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Combining LTX-315 and pembrolizumab for treating advanced melanoma before surgery
This study is testing a new treatment that combines LTX-315 and pembrolizumab to see if it helps people with advanced melanoma do better after surgery.
-
LNS8801 alone or with pembrolizumab for people whose melanoma has stopped responding.
This trial will test whether LNS8801, by itself or combined with pembrolizumab, can keep melanoma that progressed after anti‑PD‑1 therapy from growing.
Related topics
Quick answers
How many Melanoma Stage IIIB-IV clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Norway (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.